Zobrazeno 1 - 10
of 44
pro vyhledávání: ''
Autor:
Mette-Triin Purde, Rebekka Niederer, Nikolaus B. Wagner, Stefan Diem, Fiamma Berner, Omar Hasan Ali, Dorothea Hillmann, Irina Bergamin, Markus Joerger, Martin Risch, Christoph Niederhauser, Tobias L. Lenz, Martin Früh, Lorenz Risch, David Semela, Lukas Flatz
Publikováno v:
Purde, Mette‑Triin; Niederer, Rebekka; Wagner, ikolaus B.; Diem, Stefan; Berner, Fiamma; Hasan Ali, Omar; Hillmann, Dorothea; Bergamin, Irina; Joerger, Markus; Risch, Martin; Niederhauser, Christoph; Lenz, Tobias L.; Früh, Martin; Risch, Lorenz; Semela, David; Flatz, Lukas (2022). Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients. Journal of cancer research and clinical oncology, 148(3), pp. 647-656. Springer 10.1007/s00432-021-03870-6
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology
Purpose Immune checkpoint inhibitor (ICI)-induced hepatitis belongs to the frequently occurring immune-related adverse events (irAEs), particularly with the combination therapy involving ipilimumab and nivolumab. However, predisposing factors predict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::812bf92bad1e3210e93f155d71738545
https://boris.unibe.ch/162047/1/Purde2021_Article_PresenceOfAutoantibodiesInSeru.pdf
https://boris.unibe.ch/162047/1/Purde2021_Article_PresenceOfAutoantibodiesInSeru.pdf
Publikováno v:
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
Cellular Oncology, Vol 32, Iss 1-2, Pp 57-65 (2010)
Cellular Oncology, Vol 32, Iss 1-2, Pp 57-65 (2010)
Background: Patients with gastric cancer (GC) have a poor survival and biologicals such as Trastuzumab have not been used routinely in these patients. Existing data on HER2 expression and its clinical relevance in GC are still limited and controversi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1c3dd546244ad55cb07c72b3e643d86
https://ora.ox.ac.uk/objects/uuid:7bfe1b69-4071-48f2-8d28-7dea51965e5e
https://ora.ox.ac.uk/objects/uuid:7bfe1b69-4071-48f2-8d28-7dea51965e5e
Autor:
Poodt, Ingrid G. M., Schipper, Robert-Jan, de Greef, Bianca T. A., Vugts, Guusje, Maaskant-Braat, Adriana J. G., Jansen, Frits H., Wyndaele, Dirk N. J., Voogd, Adri C., Nieuwenhuijzen, Grard A. P., Roumen, R. M. H., Luiten, E. J. T., Rutgers, E. J. T., Vrancken-Peeters, M. T. F. D., Bessems, M., Klaase, J. M., Muller, S., Francken, A. B., Van Dalen, T., Koopal, S. A., Vissers, Y. L. J., Smidt, M. L., Merkus, J. W. S., Contant, C. M. E., Veldman, P. H., Linthorst-Niers, E. M. H., van der Sijp, J. R., Guicherit, O. R., Koppert, L. B., Bosch, A. M., Strobbe, L. J. A., Schlooz-Vries, M. S., Arntz, I. E., van Essen, J. A., de Waard, J. W. D., Vrouenraets, B. C., van Ooijen, B., Smidt, Marjolein
Publikováno v:
Breast Cancer Research and Treatment, 175(2), 419-428. SPRINGER
Breast Cancer Research and Treatment, 175, 2, pp. 419-428
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 175(2), 419-428. Springer, Cham
Breast Cancer Research and Treatment, 175(2), 419-428. Springer New York
Breast Cancer Research and Treatment, 175, 419-428
Breast Cancer Research and Treatment, 175, 2, pp. 419-428
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 175(2), 419-428. Springer, Cham
Breast Cancer Research and Treatment, 175(2), 419-428. Springer New York
Breast Cancer Research and Treatment, 175, 419-428
Purpose In patients with ipsilateral breast tumor recurrence (IBTR), the detection of distant disease determines whether the intention of the treatment is curative or palliative. Therefore, adequate preoperative staging is imperative for optimal trea
Autor:
Martin J. van den Bent, Katerina Bakunina, Jacoline E C Bromberg, Linda Dirven, Samar Issa, Jeanette K. Doorduijn, Matthijs van der Meulen
Publikováno v:
Journal of Neuro-Oncology, 152(2), 357-362. Kluwer Academic
Journal of Neuro-Oncology, 152(2), 357-362. SPRINGER
Journal of Neuro-Oncology
Journal of Neuro-Oncology, 152(2), 357-362. SPRINGER
Journal of Neuro-Oncology
Introduction To assess the value of the Mini-Mental State Examination (MMSE)-score at baseline in predicting survival in adult primary central nervous system lymphoma (PCNSL) patients. Methods In the HOVON 105/ ALLG NHL 24 phase III study patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a7bd8dbbae5896422024956ad26b38f
https://hdl.handle.net/1887/3251117
https://hdl.handle.net/1887/3251117
Autor:
Agustí Barnadas, Silvia M. Vidal, Margarita Majem, Leticia Alserawan, Mariona Riudavets, Carlos Zamora, Jorgina Serra, Andrés Barba, Javier Gavira, Pablo Gallardo, M. Angels Ortiz, Georgia Anguera, Lidia Perea, Ivana Sullivan
Publikováno v:
CANCER IMMUNOLOGY IMMUNOTHERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background Anti-PD-(L)1 blocking agents can induce immune-related adverse events (irAEs), which can compromise treatment continuation. Since circulating leukocyte-platelet (PLT) complexes contribute to inflammatory and autoimmune diseases, we aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e09d11d6e57947dc938268b24327bc5
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5108
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5108
Autor:
Lars Hanker, Udo Schumacher, Volkmar Müller, Frederik Marmé, Valentina Nekljudova, Peter A. Fasching, Rolf-Peter Henke, Christian Schem, Valentina Vladimirova, Sibylle Loibl, Karin Milde-Langosch, Sabine Schmatloch, Thomas Karn, Elmar Stickeler, Volker Möbus, Christine Stürken, Claus-Henning Köhne, Josef Rüschoff, Carsten Denkert
Publikováno v:
BMC cancer 21(1), 920 (2021). doi:10.1186/s12885-021-08656-0
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC cancer 21(1), 920 (2021). doi:10.1186/s12885-021-08656-0
Published by Springer, Berlin ; Heidelberg
Published by Springer, Berlin ; Heidelberg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2369003b5100c335d479a6cbb4ec4f6e
https://publications.rwth-aachen.de/record/851063
https://publications.rwth-aachen.de/record/851063
Autor:
Ignacio Ruz-Caracuel, Patricia Ruiz, Andrés Redondo, Álvaro López-Janeiro, Laura Yébenes, Alejandro Gallego, Victoria Heredia-Soto, Jorge L Ramón-Patino, Alberto Berjón, David Hardisson, Marta Mendiola, Alicia Hernández, Alberto Peláez-García
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Virchows Archiv
instname
Virchows Archiv
Low-grade and early-stage endometrioid endometrial carcinomas (EECs) have an overall good prognosis but biomarkers identifying patients at risk of relapse are still lacking. Recently, CTNNB1 exon 3 mutation has been identified as a potential risk fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d0c7fb0523a4159ae90bb1464bb2fea
http://hdl.handle.net/10486/700725
http://hdl.handle.net/10486/700725
Autor:
Ana Custodio, Carolina Hernández Pérez, Mónica Granja, Aitor Azkarate, Aitziber Gil-Negrete, Laura Visa, Manuel Cánovas, Carles Pericay Pijaume, Tamara Sauri, Patricia Morales del Burgo, Gema Aguado, Felipe Alvarez-Manceñido, Olbia Serra, Paula Jiménez-Fonseca, Nieves Martinez Lago, M. Luisa Limon, Maria Alsina, Alicia Hurtado, Aranzazu Arias-Martinez, Alfonso Martín Carnicero, Javier Gallego, Ana Montes, P. Reguera, Paola Pimentel, Juana María Cano, Rosario Vidal Tocino, Virginia Arrazubi, Alberto Carmona-Bayonas, Diego Cacho Lavin, Alba Martinez-Torron, Avinash Ramchandani, Marta Martín Richard, Raquel Hernández, Flora López
Publikováno v:
Gastric Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
Background Advanced esophageal adenocarcinoma (EAC) is generally treated similarly to advanced gastroesophageal junction (GEJ-AC) and gastric (GAC) adenocarcinomas, although GAC clinical trials rarely include EAC. This work sought to compare clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6610ee161c1b474b11a4778f667108
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4917
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4917
Autor:
Ulrike Stein, Alexander Arnold, Erika Berg, Beate Rau, C Treese, Michael Hummel, M. von Winterfeld, Severin Daum
Publikováno v:
Clinical & Translational Oncology
Introduction The tight junction molecule Claudin 18.2 is selectively expressed in healthy and malignant gastric epithelial tissue and is a promising therapy target for high Claudin 18.2 expressing adenocarcinomas of the esophagogastric junction and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba822c13c78945e6c5883f885a614365
http://edoc.mdc-berlin.de/19016/2/19016suppl.zip
http://edoc.mdc-berlin.de/19016/2/19016suppl.zip
Autor:
Mehmet Zengin
WOS: 000497411800002 PubMed: 31748877 Purpose Although local inflammatory response (LIR) is a reliable survival marker in colon cancers (CCs), there is no consensus on its use in daily practice. We investigated the prognostic value of LIR in a highly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f863fcdf9c892992e4d07136f931937
https://hdl.handle.net/20.500.12587/2756
https://hdl.handle.net/20.500.12587/2756